MedDEV News (zyk). Failed
operations, inflammatory reactions, implant loss and resulting re-operation burden the German health system with 1,000,000,000 euros annually.
Konstanz,
Germany, 23.05.2017. Chronic inflammatory reactions and poor ingrowth of
implants are the reason for the above-described complication rates. Clinical
investigations show clearly that surfaces of implants used must be
cell-attractively functionalized and engineered.
Patented MIMICKING BONE TECHNOLOGY (MBT), developed by stimOS
GmbH, works like a "stealth cap", a “magic hood” for the implant. The
patient's organism perceives the implant no longer as a piece of artificial
material, but recognizes the implant as bone-identic material - implants are
better integrated, inflammatory reactions are avoided.
This unique
refining method (MBT) can be used on all implant materials. In addition,
different active substances can be embedded in the modified implant surface.
They can be released and accurately dosed at the desired location in the
patient's body after operation.
Company Information / Profile:
stimOS GmbH, Germany.
stimOS GmbH range of services comprises a broad
series of technologies for surface activation and functionalization of medical
implants and instruments. These include conventional coating techniques as well
as innovative and customized solutions. In addition stimOS GmbH offers
subtractive as well as additive surface treatment techniques for structuring of
implant surfaces.
Keine Kommentare:
Kommentar veröffentlichen